[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f-A3mYpI0FBUTrHCYohkAGEFwmPx29Pgz5zK7Z7RhGSM":8,"$fgJW5Wklwao3j5BM1VNixoGSqQ9glVGjlXIsYHeMhL-U":54,"$f200L8Ewvf0DRZRN9ScBPq_0lWJUs0yePky1Ds1b1_oc":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":6,"postsTitle":18,"materialTotal":19,"videoTotal":20,"isConcern":7,"title":21,"coverVertical":22,"coverAcross":23,"content":24,"description":25,"views":26,"likes":20,"isThumbsUp":7,"isCollection":7,"collections":20,"createTime":27,"seoTitle":21,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":20,"isComment":41},67324,867546,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//WM89mnQfhD3TInG3npoQJOh5LNxHfOKi.png","郑迪凡","浙江大学医学院附属第一医院","住院医师",78,0,"肺癌微浸润腺癌术后常用药物使用全指南","","https://ystcdn.venuertc.com/venue/AI/167f7b86-3bdc-451d-98cc-d41440d7c67c.jpg","\u003Cdiv class=\"micra-container\">\n  \u003Ch2 id=\"material_title\" class=\"micra-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌微浸润腺癌术后常用药物使用全指南\u003C/h2>\n  \n  \u003Cdiv class=\"micra-section micra-bg-1\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">常见术后药物类别简介 🌿\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cp>\n        进行完胸腔镜下肺楔形切除术后，一般会用到几类关键药物：补液药物、镇痛药物和免疫调节剂。本文将按照药品类别，梳理每类药品的具体成分、作用机制、用法用量、相互作用、不良反应、储存等细节。我们精选了6个关键用药细节，让每一位正准备康复的朋友都能放心用药，远离意外风险。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 01 用于基础补液的常用药物 -->\n  \u003Cdiv class=\"micra-section micra-bg-2\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01｜基础补液用药：成分与用法\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cp>\n        补液治疗通常选用含有氯化钠、氯化钾、葡萄糖等溶液。它们以0.9%氯化钠注射液、5%葡萄糖注射液这类制剂最为常见。作用机制是补充失去的水分、电解质以及能量，维持体内平衡。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>正确做法：\u003C/strong>补液速度和总量应严格依照医嘱调整，通常采用静脉滴注，每小时40-100ml不等。补钾制剂需在专科医师监测下进行，绝不可自行加量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注意事项：\u003C/strong>不能与含钙溶液等药品混用，避免瓶中产生沉淀。先用清洁无菌器械操作，开封后尽快用完。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>典型用药案例：\u003C/strong>有位58岁男性患者术后使用葡萄糖-氯化钠混合补液，配合其他支持药物，出现轻微局部红肿，经更换输液部位后恢复正常。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 02 镇痛药物及其使用关键 -->\n  \u003Cdiv class=\"micra-section micra-bg-3\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02｜镇痛药物：剂型、用法与安全剂量💡\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cp>\n        术后镇痛常选用非甾体抗炎药（如布洛芬、氟比洛芬酯注射液）、阿片类药物（如曲马多、吗啡等）。非甾体抗炎药主要通过抑制前列腺素合成缓解疼痛；阿片类则作用于中枢神经系统。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>正确做法：\u003C/strong>非甾体抗炎药口服或静脉注射，成人单次用量常为布洛芬200-400mg，每隔6-8小时1次。阿片类需要密切监测呼吸、意识变化，不能自行增减。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>服用技巧：\u003C/strong>肠溶型布洛芬不能嚼碎，需整片吞服，一般选择餐后服用以减少胃部刺激。注射药物开瓶后4小时内用完。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>不良反应处理：\u003C/strong>布洛芬可能引起胃肠不适、出血风险，曲马多可能导致头晕、恶心。如出现消化道异常，应暂停并告知医生。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>文献支持：\u003C/strong>\n        \u003Cem>Meek, I.L., van de Laar, M.A., &amp; Vonkeman, H.E. (2010). Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks. Pharmaceuticals, 3(7), 2146–2162.\u003C/em>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 03 免疫调节剂及联合用药事项 -->\n  \u003Cdiv class=\"micra-section micra-bg-4\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03｜免疫调节剂：配伍与禁忌清单🧬\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cp>\n        免疫调节剂如胸腺肽、聚肌胞等，帮助调整患者免疫功能。它们通过刺激T细胞或者增强机体抗感染能力起作用，辅佐手术后的全面恢复。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>使用方法：\u003C/strong>胸腺肽常见为注射剂，每次1.6mg-10mg不等，每周2-3次。聚肌胞1mg溶于葡萄糖水注射静脉。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>禁忌须知：\u003C/strong>已知对蛋白药物过敏者不可用。免疫抑制剂治疗期间禁用免疫增强剂，以免药效抵消。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>案例提醒：\u003C/strong>临床一例患者接受胸腺肽期间，合并使用激素类药物后出现免疫反应减弱问题，需医生严格评估联合用药必要性。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>文献支持：\u003C/strong>\n        \u003Cem>Gonzalez, H., Hagerling, C., &amp; Werb, Z. (2018). Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes &amp; Development, 32(19-20), 1267-1284.\u003C/em>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 04 药物相互作用与联合用药警示 -->\n  \u003Cdiv class=\"micra-section micra-bg-5\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04｜药物相互作用与联合用药的6个细节⚠️\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>1. 阿片镇痛药＋镇静药：\u003C/strong>两类药合用会增强呼吸抑制，应严格监控呼吸。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>2. 非甾体抗炎药＋抗凝药：\u003C/strong>可能增加出血风险，建议避开合用或减少剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>3. 补钾剂＋ACEI/ARB：\u003C/strong>共同使用时高钾血症风险加大，需监测试验室指标。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>4. 聚肌胞/胸腺肽＋免疫抑制剂：\u003C/strong>药效可能互相抵消，不建议同时服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>5. 输液药品严禁“混瓶”：\u003C/strong>有的药物混合后会产生沉淀或失效，必须分开使用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>6. 注意与中药冲突：\u003C/strong>部分免疫调节剂与强刺激性中药有潜在冲突，服用时请先咨询药师。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>每次联合用药，都应主动和医生核查药物清单。药物说明书也是核查冲突的好帮手。\u003C/p>\n      \u003Cp>\n        \u003Cstrong>文献支持：\u003C/strong>\n        \u003Cem>Juurlink, D.N., Mamdani, M.M., Kopp, A., &amp; Redelmeier, D.A. (2003). Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA, 289(13), 1652–1658.\u003C/em>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 05 药物不良反应与处理对策 -->\n  \u003Cdiv class=\"micra-section micra-bg-6\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05｜使用过程中的常见不良反应与应对措施☔️\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>补液药物：\u003C/strong>外渗可能引起皮肤红肿，局部冷敷有一定缓解作用。超量补液容易导致水肿，须减少输液速度。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>镇痛药：\u003C/strong>非甾体抗炎药服用后约2-6%患者会有胃肠不适。阿片类药物常见恶心、便秘，建立清单并及时反馈变化。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫调节剂：\u003C/strong>5%以内患者会出现注射部位疼痛或低热，大多无需停药。如出现严重过敏，应立即就医。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>处理方法：\u003C/strong>轻症可以暂停或更换药物，重症（如喉头水肿、窒息等）要第一时间求助紧急医疗救治。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 06 储存、有效期与注意事项 -->\n  \u003Cdiv class=\"micra-section micra-bg-1\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06｜药品储存与有效期全攻略📦\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>液体制剂：\u003C/strong>氯化钠、葡萄糖等应存放于15℃-30℃阴凉、干燥处。拆封后24小时内用完。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>肠溶片：\u003C/strong>布洛芬肠溶片避光保存，勿压碎或切分。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>粉针剂：\u003C/strong>胸腺肽等溶液建议现用现配，配好后4小时内用完。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>过期药品：\u003C/strong>过期药不能继续服用，统一放入专用回收点或咨询药师正确处理办法。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>环境细节：\u003C/strong>避免潮湿，远离强光和儿童接触区域。如遇瓶体漏液、片剂变色，切勿使用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 07 用药过程中漏服与过量应对 -->\n  \u003Cdiv class=\"micra-section micra-bg-2\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07｜漏服、过量的紧急处理🔔\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>漏服：\u003C/strong>若发现漏服，应尽快补服1次。但快到下次服药时间时，跳过漏服，按顺序服用。不要一次服两倍剂量。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>过量：\u003C/strong>过量使用布洛芬、阿片类容易引起严重副作用（如肝肾损伤、意识混乱），一旦服药过量应立即携带药品说明书就医。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>补液过量：\u003C/strong>短时间大量补液会导致水中毒，应及时暂停补液并就诊。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>急救联系方式：\u003C/strong>储存所属药品包装盒上的紧急电话，关键时刻能提供帮助。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 结尾和总结 -->\n  \u003Cdiv class=\"micra-section micra-bg-3 micra-summary-section\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语\u003C/h2>\n    \u003Cdiv class=\"micra-content\">\n      \u003Cp>\n        术后用药没有想象中复杂，但关键细节绝对不能忽视。补液、镇痛和免疫调节剂每一类药物都各有“玩法”和禁忌，联合用药、监测副反应、储存方式每一步都关乎康复。最好每次服药前认真阅读说明书，并主动和医生、药师沟通。\u003Cspan class=\"micra-highlight\">安全用药，细节先行！\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 参考文献 -->\n  \u003Cdiv class=\"micra-section micra-bg-4 micra-ref-section\">\n    \u003Ch2 class=\"micra-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cdiv class=\"micra-ref-list\">\n      \u003Cul>\n        \u003Cli>\n          Meek, I.L., van de Laar, M.A., &amp; Vonkeman, H.E. (2010). Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks. \u003Ci>Pharmaceuticals, 3\u003C/i>(7), 2146–2162.\n        \u003C/li>\n        \u003Cli>\n          Gonzalez, H., Hagerling, C., &amp; Werb, Z. (2018). Roles of the immune system in cancer: from tumor initiation to metastatic progression. \u003Ci>Genes &amp; Development, 32\u003C/i>(19-20), 1267-1284.\n        \u003C/li>\n        \u003Cli>\n          Juurlink, D.N., Mamdani, M.M., Kopp, A., &amp; Redelmeier, D.A. (2003). Drug-drug interactions among elderly patients hospitalized for drug toxicity. \u003Ci>JAMA, 289\u003C/i>(13), 1652–1658.\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.micra-container {\n  font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Microsoft YaHei', sans-serif;\n  color: #23272f;\n  background-color: #fcfcfc;\n  margin: 0 auto;\n  padding: 20px 6%;\n  max-width: 860px;\n  border-radius: 14px;\n  box-shadow: 0 2px 16px 0 rgba(70,75,106,0.12);\n}\n\n.micra-main-title {\n  font-size: 2.22em;\n  color: #314255;\n  font-weight: 700;\n  letter-spacing: 1px;\n  padding: 26px 0 16px 0;\n  border-bottom: 2px solid #c7d1e0;\n}\n\n.micra-section {\n  margin-top: 28px;\n  padding: 32px 28px 24px 28px;\n  border-radius: 13px;\n  box-sizing: border-box;\n  background-size: cover;\n  background-repeat: no-repeat;\n}\n\n.micra-bg-1 { background: linear-gradient(103deg, #f5fafc 0%, #eef1fb 90%);}\n.micra-bg-2 { background: linear-gradient(98deg, #f7f7fd 0%, #e0eeef 100%);}\n.micra-bg-3 { background: linear-gradient(97deg, #f8fdf6 0%, #e9f1ee 100%);}\n.micra-bg-4 { background: linear-gradient(92deg, #f3f9fd 0%, #f5eef8 100%);}\n.micra-bg-5 { background: linear-gradient(95deg, #f6fbf9 0%, #effcf2 100%);}\n.micra-bg-6 { background: linear-gradient(90deg, #f8fbe8 0%, #f5f5fa 100%);}\n\n.micra-section-title {\n  font-size: 1.45em;\n  color: #226D94;\n  margin-bottom: 19px;\n  font-weight: 600;\n  letter-spacing: 0.8px;\n  background: rgba(255,255,255,0.52);\n  padding: 10px 24px;\n  border-radius: 8px;\n  box-shadow: 0 1px 8px 0 rgba(74,103,160,0.06);\n  display: inline-block;\n}\n\n.micra-content {\n  font-size: 1.08em;\n  color: #2f3544;\n  line-height: 1.95;\n  margin-left: 5px;\n  margin-right: 5px;\n}\n\n.micra-content ul {\n  margin: 10px 0 10px 25px;\n  padding: 0;\n}\n\n.micra-content ul li {\n  margin-bottom: 12px;\n  line-height: 1.82;\n  font-size: 1.01em;\n}\n\n.micra-content p, .micra-content ul li {\n  word-break: break-all;\n}\n\n.micra-content strong {\n  color: #0a5886;\n  font-weight: 600;\n}\n\n.micra-summary-section .micra-content {\n  font-size: 1.12em;\n  color: #224669;\n}\n\n.micra-highlight {\n  background-color: #fffbe7;\n  padding: 0 8px;\n  border-radius: 5px;\n  color: #d18315;\n  font-weight: 700;\n}\n\n.micra-ref-section {\n  margin-top: 33px;\n  padding-top: 18px;\n  padding-bottom: 22px;\n  font-size: 1em;\n  background: linear-gradient(130deg, #eef6fb 30%, #fcfcfc 110%);\n}\n\n.micra-ref-section ul {\n  margin: 0 0 0 18px;\n  padding: 0;\n}\n\n.micra-ref-list li {\n  margin-bottom: 8px;\n  line-height: 1.8;\n}\n\u003C/style>\n\n","\u003Cdiv class=\"micra-container\">\n  \u003Ch2 id=\"material_title\" class=\"micra-main-title\" style=\"color: rgb(4",573,"2025-09-26 16:58:43","肺癌微浸润腺癌, 术后用药, 补液药物, 镇痛药, 免疫调节剂, 药物相互作用, 不良反应, 医疗指南","本文提供肺癌微浸润腺癌术后用药的全面指南，涵盖补液、镇痛及免疫调节剂等药物的使用方法与注意事项，帮助患者安全康复。","2025-10-04 16:30:00",2,[33],{"menuId":34,"menuName":35,"parentId":20,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":20,"createDept":6,"remark":22,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":20,"forceLogin":20,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":20},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]